Antiphospholipase A2 receptor antibody levels predict the risk of posttransplantation recurrence of membranous nephropathy

Transplantation

Volumn 99, Issue 8, 2015, Pages 1709-1714

  Quintana, Luis F ^a   Blasco, Miquel ^a   Seras, Miguel ^b   Pérez, Nuria S ^a   López Hoyos, Marcos ^c   Villarroel, Patricia ^d   Rodrigo, Emilio ^b   Viñas, Odette ^d   Ercilla, Guadalupe ^d   Diekmann, Fritz ^a   Gómez Roman, José J ^b   Fernandez Fresnedo, Gema ^b   Oppenheimer, Federico ^a   Arias, Manuel ^b   Campistol, Josep M ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^c UNIVERSITY OF CANTABRIA   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALEFACEPT; BASILIXIMAB; CALCINEURIN INHIBITOR; DACLIZUMAB; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MYCOPHENOLIC ACID; PHOSPHOLIPASE A2 RECEPTOR ANTIBODY; RECEPTOR ANTIBODY; RITUXIMAB; STEROID; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG; AUTOANTIBODY; BIOLOGICAL MARKER; HLA DQ ANTIGEN; PHOSPHOLIPASE A2 RECEPTOR; PLA2R1 PROTEIN, HUMAN;

ADULT; AGED; ALLELE; ANTIBODY BLOOD LEVEL; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GRAFT RECIPIENT; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MAINTENANCE THERAPY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MIDDLE AGED; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; ADVERSE EFFECTS; BIOPSY; BLOOD; CLINICAL TRIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; GLOMERULONEPHRITIS, MEMBRANOUS; IMMUNOLOGY; MULTICENTER STUDY; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK ASSESSMENT; SPAIN; TIME; TREATMENT OUTCOME;

ADULT; AGED; AREA UNDER CURVE; AUTOANTIBODIES; BIOLOGICAL MARKERS; BIOPSY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULONEPHRITIS, MEMBRANOUS; HLA-DQ ANTIGENS; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RECEPTORS, PHOSPHOLIPASE A2; RECURRENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; SPAIN; TIME FACTORS; TREATMENT OUTCOME;

EID: 84934780458     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000630     Document Type: Article

References (21)

1. Glassock RJ. The pathogenesis of idiopathic membranous nephropathy: a 50-year odyssey. Am J Kidney Dis. 2010;56:157-167.
2. Dabade TS, Grande JP, Norby SM, Fervenza FC, Cosio FG. Recurrent idiopathic membranous nephropathy after kidney transplantation: a surveillance biopsy study. Am J Transplant. 2008;8:1318-1322.
3. El-Zoghby ZM, Grande JP, Fraile MG, Norby SM, Fervenza FC, Cosio FG. Recurrent idiopathicmembranous nephropathy: early diagnosis by protocol biopsies and treatment with anti-CD20 monoclonal antibodies. Am J Transplant. 2009;9:2800-2807.
4. Moroni G, Gallelli B, Quaglini S, et al. Long-term outcome of renal transplantation in patients with idiopathic membranous glomerulonephritis (MN). Nephrol Dial Transplant. 2010;25:3408-3415.
5. Couchoud C, Pouteil-Noble C, Colon S, Touraine JL. Recurrence of membranous nephropathy after renal transplantation. Incidence and risk factors in 1614 patients. Transplantation. 1995;59:1275-1279.
6. Heymann W, Hackel DB, Harwood S, Wilson SG, Hunter JL. Production of nephrotic syndrome in rats by Freund's adjuvants and rat kidney suspensions. Proc Soc Exp Biol Med. 1959;100(4):660-664.
7. Debiec H, Guigonis V, Mougenot B, et al. Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med. 2002;346(26):2053-2060.
8. Beck LH Jr, Bonegio RG, Lambeau G, et al. M-Type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361(1):11-21.
9. Debiec H, Ronco P. PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy. N Engl JMed. 2011;364:689-690.
10. Hoxha E, Harendza S, Zahner G, et al. An immunofluorescence test for phospholipase-A(2)-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. Nephrol Dial Transplant. 2011;26:2526-2532.
11. Kanigicherla D, Gummadova J, McKenzie EA, et al. Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy. Kidney Int. 2013;83:940-948.
12. Hofstra JM, Debiec H, Short CD, et al. Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy. J Am Soc Nephrol. 2012;23(10):1735-1743.
13. Coenen MJ, Hofstra JM, Debiec H, et al. Phospholipase A2 receptor (PLA2R1) sequence variants in idiopathic membranous nephropathy. J Am Soc Nephrol. 2013;24:677-683.
14. Stahl R, Hoxha E, Fechner K. PLA2R autoantibodies and recurrent membranousnephropathy after transplantation. N Engl J Med. 2010;363:496-498.
15. Blosser CD, Ayalon R, Nair R, Thomas C, Beck LH Jr. Very early recurrence of anti-phospholipase A2 receptor-positive membranous nephropathy after transplantation. Am J Transplant. 2012;12(6):1637-1642.
16. Debiec H, Martin L, Jouanneau C, et al. Autoantibodies specific for the phospholipase A(2) receptor in recurrent and de novo membranous nephropathy. Am J Transplant. 2011;11:2144-2152.
17. Seitz-Polski B, Payré C, Ambrosetti D, et al. Prediction of membranous nephropathy recurrence after transplantation by monitoring of anti-PLA2R1 (M-type phospholipase A2 receptor) autoantibodies: a case series of 15 patients. Nephrol Dial Transplant. 2014;29:2334-2342.
18. Cosyns JP, Pouteil-Noble C, Squifflet JP, Pirson Y. Recurrence of membranous nephropathy after renal transplantation: Probability, outcome and risk factors. Clin Nephrol. 1998;50:144-153.
19. Andrésdóttir MB, Wetzels JF. Increased risk of recurrence ofmembranous nephropathy after related donor kidney transplantation. Am J Transplant. 2012;12(1):265-266.
20. Stanescu HC, Arcos-Burgos M, Medlar A, et al. Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. N Engl J Med. 2011;364:616-626.
21. Pillai S, Mattoo H, Cariappa A. B cells and autoimmunity. Curr Opin Immunol. 2011;23(6):721-731.